img

Global Zonisamide Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Zonisamide Market Insights, Forecast to 2034

Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
Global Zonisamide market is expected to reach to US$ 501 million in 2024, with a positive growth of %, compared with US$ 489 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Zonisamide industry is evaluated to reach US$ 718.8 million in 2029. The CAGR will be 6.2% during 2024 to 2029.
Globally, Zonisamide key manufacturers include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. Concordia, Eisai, Zydus Pharmaceuticals are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Zonisamide were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Zonisamide market and estimated to attract more attentions from industry insiders and investors.
Zonisamide can be divided into 25mg, 50mg and 100mg,, etc. 25mg is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Zonisamide is widely used in various fields, such as Adult, Pediatric and Geriatric,, etc. Adult provides greatest supports to the Zonisamide industry development. In 2022, global % sales of Zonisamide went into Adult filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Zonisamide market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Zonisamide market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg

Segment by Application


Adult
Pediatric
Geriatric

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Zonisamide plant distribution, commercial date of Zonisamide, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Zonisamide introduction, etc. Zonisamide Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Zonisamide
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Zonisamide Product Introduction
1.2 Market by Type
1.2.1 Global Zonisamide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Market by Application
1.3.1 Global Zonisamide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Pediatric
1.3.4 Geriatric
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Zonisamide Sales Estimates and Forecasts 2018-2029
2.2 Global Zonisamide Revenue by Region
2.2.1 Global Zonisamide Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Zonisamide Revenue by Region (2018-2024)
2.2.3 Global Zonisamide Revenue by Region (2024-2029)
2.2.4 Global Zonisamide Revenue Market Share by Region (2018-2029)
2.3 Global Zonisamide Sales Estimates and Forecasts 2018-2029
2.4 Global Zonisamide Sales by Region
2.4.1 Global Zonisamide Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Zonisamide Sales by Region (2018-2024)
2.4.3 Global Zonisamide Sales by Region (2024-2029)
2.4.4 Global Zonisamide Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Zonisamide Sales by Manufacturers
3.1.1 Global Zonisamide Sales by Manufacturers (2018-2024)
3.1.2 Global Zonisamide Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Zonisamide in 2022
3.2 Global Zonisamide Revenue by Manufacturers
3.2.1 Global Zonisamide Revenue by Manufacturers (2018-2024)
3.2.2 Global Zonisamide Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Zonisamide Revenue in 2022
3.3 Global Key Players of Zonisamide, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Zonisamide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Zonisamide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Zonisamide, Product Offered and Application
3.8 Global Key Manufacturers of Zonisamide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Zonisamide Sales by Type
4.1.1 Global Zonisamide Historical Sales by Type (2018-2024)
4.1.2 Global Zonisamide Forecasted Sales by Type (2024-2029)
4.1.3 Global Zonisamide Sales Market Share by Type (2018-2029)
4.2 Global Zonisamide Revenue by Type
4.2.1 Global Zonisamide Historical Revenue by Type (2018-2024)
4.2.2 Global Zonisamide Forecasted Revenue by Type (2024-2029)
4.2.3 Global Zonisamide Revenue Market Share by Type (2018-2029)
4.3 Global Zonisamide Price by Type
4.3.1 Global Zonisamide Price by Type (2018-2024)
4.3.2 Global Zonisamide Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Zonisamide Sales by Application
5.1.1 Global Zonisamide Historical Sales by Application (2018-2024)
5.1.2 Global Zonisamide Forecasted Sales by Application (2024-2029)
5.1.3 Global Zonisamide Sales Market Share by Application (2018-2029)
5.2 Global Zonisamide Revenue by Application
5.2.1 Global Zonisamide Historical Revenue by Application (2018-2024)
5.2.2 Global Zonisamide Forecasted Revenue by Application (2024-2029)
5.2.3 Global Zonisamide Revenue Market Share by Application (2018-2029)
5.3 Global Zonisamide Price by Application
5.3.1 Global Zonisamide Price by Application (2018-2024)
5.3.2 Global Zonisamide Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Zonisamide Market Size by Type
6.1.1 US & Canada Zonisamide Sales by Type (2018-2029)
6.1.2 US & Canada Zonisamide Revenue by Type (2018-2029)
6.2 US & Canada Zonisamide Market Size by Application
6.2.1 US & Canada Zonisamide Sales by Application (2018-2029)
6.2.2 US & Canada Zonisamide Revenue by Application (2018-2029)
6.3 US & Canada Zonisamide Market Size by Country
6.3.1 US & Canada Zonisamide Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Zonisamide Sales by Country (2018-2029)
6.3.3 US & Canada Zonisamide Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Zonisamide Market Size by Type
7.1.1 Europe Zonisamide Sales by Type (2018-2029)
7.1.2 Europe Zonisamide Revenue by Type (2018-2029)
7.2 Europe Zonisamide Market Size by Application
7.2.1 Europe Zonisamide Sales by Application (2018-2029)
7.2.2 Europe Zonisamide Revenue by Application (2018-2029)
7.3 Europe Zonisamide Market Size by Country
7.3.1 Europe Zonisamide Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Zonisamide Sales by Country (2018-2029)
7.3.3 Europe Zonisamide Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Zonisamide Market Size
8.1.1 China Zonisamide Sales (2018-2029)
8.1.2 China Zonisamide Revenue (2018-2029)
8.2 China Zonisamide Market Size by Application
8.2.1 China Zonisamide Sales by Application (2018-2029)
8.2.2 China Zonisamide Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Zonisamide Market Size by Type
9.1.1 Asia Zonisamide Sales by Type (2018-2029)
9.1.2 Asia Zonisamide Revenue by Type (2018-2029)
9.2 Asia Zonisamide Market Size by Application
9.2.1 Asia Zonisamide Sales by Application (2018-2029)
9.2.2 Asia Zonisamide Revenue by Application (2018-2029)
9.3 Asia Zonisamide Sales by Region
9.3.1 Asia Zonisamide Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Zonisamide Revenue by Region (2018-2029)
9.3.3 Asia Zonisamide Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Zonisamide Market Size by Type
10.1.1 Middle East, Africa and Latin America Zonisamide Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Zonisamide Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Zonisamide Market Size by Application
10.2.1 Middle East, Africa and Latin America Zonisamide Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Zonisamide Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Zonisamide Sales by Country
10.3.1 Middle East, Africa and Latin America Zonisamide Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Zonisamide Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Zonisamide Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Concordia
11.1.1 Concordia Company Information
11.1.2 Concordia Overview
11.1.3 Concordia Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Concordia Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Concordia Recent Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Overview
11.2.3 Eisai Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Eisai Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eisai Recent Developments
11.3 Zydus Pharmaceuticals
11.3.1 Zydus Pharmaceuticals Company Information
11.3.2 Zydus Pharmaceuticals Overview
11.3.3 Zydus Pharmaceuticals Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Zydus Pharmaceuticals Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zydus Pharmaceuticals Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Company Information
11.4.2 Sun Pharma Overview
11.4.3 Sun Pharma Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sun Pharma Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharma Recent Developments
11.5 Wockhardt
11.5.1 Wockhardt Company Information
11.5.2 Wockhardt Overview
11.5.3 Wockhardt Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Wockhardt Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wockhardt Recent Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Overview
11.6.3 Mylan Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Mylan Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 APOTEX
11.7.1 APOTEX Company Information
11.7.2 APOTEX Overview
11.7.3 APOTEX Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 APOTEX Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 APOTEX Recent Developments
11.8 Teva
11.8.1 Teva Company Information
11.8.2 Teva Overview
11.8.3 Teva Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Teva Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Recent Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Overview
11.9.3 Glenmark Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Glenmark Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Recent Developments
11.10 Bluepharma
11.10.1 Bluepharma Company Information
11.10.2 Bluepharma Overview
11.10.3 Bluepharma Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Bluepharma Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bluepharma Recent Developments
11.11 Invagen Pharmaceuticals
11.11.1 Invagen Pharmaceuticals Company Information
11.11.2 Invagen Pharmaceuticals Overview
11.11.3 Invagen Pharmaceuticals Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Invagen Pharmaceuticals Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Invagen Pharmaceuticals Recent Developments
11.12 Intas Pharmaceuticals
11.12.1 Intas Pharmaceuticals Company Information
11.12.2 Intas Pharmaceuticals Overview
11.12.3 Intas Pharmaceuticals Zonisamide Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Intas Pharmaceuticals Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Intas Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Zonisamide Industry Chain Analysis
12.2 Zonisamide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Zonisamide Production Mode & Process
12.4 Zonisamide Sales and Marketing
12.4.1 Zonisamide Sales Channels
12.4.2 Zonisamide Distributors
12.5 Zonisamide Customers
13 Market Dynamics
13.1 Zonisamide Industry Trends
13.2 Zonisamide Market Drivers
13.3 Zonisamide Market Challenges
13.4 Zonisamide Market Restraints
14 Key Findings in The Global Zonisamide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Zonisamide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 25mg
Table 3. Major Manufacturers of 50mg
Table 4. Major Manufacturers of 100mg
Table 5. Global Zonisamide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Zonisamide Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Zonisamide Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Zonisamide Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Zonisamide Revenue Market Share by Region (2018-2024)
Table 10. Global Zonisamide Revenue Market Share by Region (2024-2029)
Table 11. Global Zonisamide Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Zonisamide Sales by Region (2018-2024) & (K Units)
Table 13. Global Zonisamide Sales by Region (2024-2029) & (K Units)
Table 14. Global Zonisamide Sales Market Share by Region (2018-2024)
Table 15. Global Zonisamide Sales Market Share by Region (2024-2029)
Table 16. Global Zonisamide Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Zonisamide Sales Share by Manufacturers (2018-2024)
Table 18. Global Zonisamide Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Zonisamide Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Zonisamide, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Zonisamide Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Zonisamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Zonisamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zonisamide as of 2022)
Table 24. Global Key Manufacturers of Zonisamide, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Zonisamide, Product Offered and Application
Table 26. Global Key Manufacturers of Zonisamide, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Zonisamide Sales by Type (2018-2024) & (K Units)
Table 29. Global Zonisamide Sales by Type (2024-2029) & (K Units)
Table 30. Global Zonisamide Sales Share by Type (2018-2024)
Table 31. Global Zonisamide Sales Share by Type (2024-2029)
Table 32. Global Zonisamide Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Zonisamide Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Zonisamide Revenue Share by Type (2018-2024)
Table 35. Global Zonisamide Revenue Share by Type (2024-2029)
Table 36. Zonisamide Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Zonisamide Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Zonisamide Sales by Application (2018-2024) & (K Units)
Table 39. Global Zonisamide Sales by Application (2024-2029) & (K Units)
Table 40. Global Zonisamide Sales Share by Application (2018-2024)
Table 41. Global Zonisamide Sales Share by Application (2024-2029)
Table 42. Global Zonisamide Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Zonisamide Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Zonisamide Revenue Share by Application (2018-2024)
Table 45. Global Zonisamide Revenue Share by Application (2024-2029)
Table 46. Zonisamide Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Zonisamide Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Zonisamide Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Zonisamide Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Zonisamide Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Zonisamide Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Zonisamide Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Zonisamide Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Zonisamide Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Zonisamide Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Zonisamide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Zonisamide Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Zonisamide Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Zonisamide Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Zonisamide Sales by Country (2024-2029) & (K Units)
Table 61. Europe Zonisamide Sales by Type (2018-2024) & (K Units)
Table 62. Europe Zonisamide Sales by Type (2024-2029) & (K Units)
Table 63. Europe Zonisamide Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Zonisamide Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Zonisamide Sales by Application (2018-2024) & (K Units)
Table 66. Europe Zonisamide Sales by Application (2024-2029) & (K Units)
Table 67. Europe Zonisamide Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Zonisamide Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Zonisamide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Zonisamide Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Zonisamide Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Zonisamide Sales by Country (2018-2024) & (K Units)
Table 73. Europe Zonisamide Sales by Country (2024-2029) & (K Units)
Table 74. China Zonisamide Sales by Type (2018-2024) & (K Units)
Table 75. China Zonisamide Sales by Type (2024-2029) & (K Units)
Table 76. China Zonisamide Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Zonisamide Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Zonisamide Sales by Application (2018-2024) & (K Units)
Table 79. China Zonisamide Sales by Application (2024-2029) & (K Units)
Table 80. China Zonisamide Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Zonisamide Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Zonisamide Sales by Type (2018-2024) & (K Units)
Table 83. Asia Zonisamide Sales by Type (2024-2029) & (K Units)
Table 84. Asia Zonisamide Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Zonisamide Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Zonisamide Sales by Application (2018-2024) & (K Units)
Table 87. Asia Zonisamide Sales by Application (2024-2029) & (K Units)
Table 88. Asia Zonisamide Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Zonisamide Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Zonisamide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Zonisamide Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Zonisamide Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Zonisamide Sales by Region (2018-2024) & (K Units)
Table 94. Asia Zonisamide Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Zonisamide Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Zonisamide Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Zonisamide Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Zonisamide Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Zonisamide Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Zonisamide Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Zonisamide Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Zonisamide Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Zonisamide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Zonisamide Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Zonisamide Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Zonisamide Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Zonisamide Sales by Country (2024-2029) & (K Units)
Table 108. Concordia Company Information
Table 109. Concordia Description and Major Businesses
Table 110. Concordia Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Concordia Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Concordia Recent Developments
Table 113. Eisai Company Information
Table 114. Eisai Description and Major Businesses
Table 115. Eisai Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Eisai Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Eisai Recent Developments
Table 118. Zydus Pharmaceuticals Company Information
Table 119. Zydus Pharmaceuticals Description and Major Businesses
Table 120. Zydus Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Zydus Pharmaceuticals Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Zydus Pharmaceuticals Recent Developments
Table 123. Sun Pharma Company Information
Table 124. Sun Pharma Description and Major Businesses
Table 125. Sun Pharma Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Sun Pharma Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sun Pharma Recent Developments
Table 128. Wockhardt Company Information
Table 129. Wockhardt Description and Major Businesses
Table 130. Wockhardt Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Wockhardt Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Wockhardt Recent Developments
Table 133. Mylan Company Information
Table 134. Mylan Description and Major Businesses
Table 135. Mylan Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Mylan Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Mylan Recent Developments
Table 138. APOTEX Company Information
Table 139. APOTEX Description and Major Businesses
Table 140. APOTEX Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. APOTEX Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. APOTEX Recent Developments
Table 143. Teva Company Information
Table 144. Teva Description and Major Businesses
Table 145. Teva Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Teva Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Teva Recent Developments
Table 148. Glenmark Company Information
Table 149. Glenmark Description and Major Businesses
Table 150. Glenmark Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Glenmark Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Glenmark Recent Developments
Table 153. Bluepharma Company Information
Table 154. Bluepharma Description and Major Businesses
Table 155. Bluepharma Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Bluepharma Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Bluepharma Recent Developments
Table 158. Invagen Pharmaceuticals Company Information
Table 159. Invagen Pharmaceuticals Description and Major Businesses
Table 160. Invagen Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Invagen Pharmaceuticals Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Invagen Pharmaceuticals Recent Developments
Table 163. Intas Pharmaceuticals Company Information
Table 164. Intas Pharmaceuticals Description and Major Businesses
Table 165. Intas Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Intas Pharmaceuticals Zonisamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Intas Pharmaceuticals Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Zonisamide Distributors List
Table 171. Zonisamide Customers List
Table 172. Zonisamide Market Trends
Table 173. Zonisamide Market Drivers
Table 174. Zonisamide Market Challenges
Table 175. Zonisamide Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Zonisamide Product Picture
Figure 2. Global Zonisamide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Zonisamide Market Share by Type in 2022 & 2029
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. 100mg Product Picture
Figure 7. Global Zonisamide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Zonisamide Market Share by Application in 2022 & 2029
Figure 9. Adult
Figure 10. Pediatric
Figure 11. Geriatric
Figure 12. Zonisamide Report Years Considered
Figure 13. Global Zonisamide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Zonisamide Revenue 2018-2029 (US$ Million)
Figure 15. Global Zonisamide Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Zonisamide Revenue Market Share by Region (2018-2029)
Figure 17. Global Zonisamide Sales 2018-2029 ((K Units)
Figure 18. Global Zonisamide Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Zonisamide Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Zonisamide Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Zonisamide Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Zonisamide Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Zonisamide Sales YoY (2018-2029) & (K Units)
Figure 24. China Zonisamide Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Zonisamide Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Zonisamide Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Zonisamide Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Zonisamide Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Zonisamide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Zonisamide in the World: Market Share by Zonisamide Revenue in 2022
Figure 31. Global Zonisamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Zonisamide Sales Market Share by Type (2018-2029)
Figure 33. Global Zonisamide Revenue Market Share by Type (2018-2029)
Figure 34. Global Zonisamide Sales Market Share by Application (2018-2029)
Figure 35. Global Zonisamide Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Zonisamide Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Zonisamide Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Zonisamide Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Zonisamide Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Zonisamide Revenue Share by Country (2018-2029)
Figure 41. US & Canada Zonisamide Sales Share by Country (2018-2029)
Figure 42. U.S. Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Zonisamide Sales Market Share by Type (2018-2029)
Figure 45. Europe Zonisamide Revenue Market Share by Type (2018-2029)
Figure 46. Europe Zonisamide Sales Market Share by Application (2018-2029)
Figure 47. Europe Zonisamide Revenue Market Share by Application (2018-2029)
Figure 48. Europe Zonisamide Revenue Share by Country (2018-2029)
Figure 49. Europe Zonisamide Sales Share by Country (2018-2029)
Figure 50. Germany Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 51. France Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 55. China Zonisamide Sales Market Share by Type (2018-2029)
Figure 56. China Zonisamide Revenue Market Share by Type (2018-2029)
Figure 57. China Zonisamide Sales Market Share by Application (2018-2029)
Figure 58. China Zonisamide Revenue Market Share by Application (2018-2029)
Figure 59. Asia Zonisamide Sales Market Share by Type (2018-2029)
Figure 60. Asia Zonisamide Revenue Market Share by Type (2018-2029)
Figure 61. Asia Zonisamide Sales Market Share by Application (2018-2029)
Figure 62. Asia Zonisamide Revenue Market Share by Application (2018-2029)
Figure 63. Asia Zonisamide Revenue Share by Region (2018-2029)
Figure 64. Asia Zonisamide Sales Share by Region (2018-2029)
Figure 65. Japan Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 69. India Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Zonisamide Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Zonisamide Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Zonisamide Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Zonisamide Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Zonisamide Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Zonisamide Sales Share by Country (2018-2029)
Figure 76. Brazil Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Zonisamide Revenue (2018-2029) & (US$ Million)
Figure 81. Zonisamide Value Chain
Figure 82. Zonisamide Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries